Cash-strapped Epirus to sell CHO platform and biosimilar IP to Polpharma for $3.5m
As part of a cost-savings restructure, Epirus is selling the assets from its $14m acquisition of Bioceros last September to its biosimilars partner Polpharma.
Archives for June 14, 2016
ProteoNic aims to provide biopharma with MSO-free alternative for cell selection
ProteoNic Biotechnology has licensed a vector gene delivery system to Horizon Discovery in a deal it hopes will attract firms looking to eliminate methionine sulphoximine from CHO cell selection processes.
Sartorius: Upstream filter offers 'virus insurance' for biomanufacturers
Virus filters have traditionally been used in downstream processes, but Sartorius’s Virosart Media for upstream is a gamechanger, the firm says.